News
New research results reported at the International Conference® 2025 (AAIC®) advanced scientific understanding of ...
Indian pharma is hoping to cash in. Generic firms, such as Biocon, are already offering weight-loss drugs, such as cheaper ...
Eli Lilly said on Thursday that its newer diabetes drug Mounjaro outperformed Trulicity, its previously top-selling ...
The intestines are home to trillions of microorganisms that produce substances capable of regulating all the body's organs ...
Nearly 60,000 new students have been offered a place in higher education, and many now face the challenge of finding somewhere to live. With the start of the academic year, pressure on the housing ...
Novo Nordisk (NYSE:NVO) is one of the most profitable value stocks to buy according to analysts. On July 25, Novo Nordisk ...
Wegovy, the blockbuster weight-loss drug, is now available in Singapore more than two years after it was approved by the ...
The persistent threat of reciprocal tariffs from US President Donald Trump has resulted in many trade deals, while the IMF ...
Wall Street is reacting with downgrades to Novo's earnings, but with shares trading at their lowest valuation in years, ...
Novo Nordisk promoted Maziar Mike Doustdar to president and CEO, effective August 7. The Food and Drug Administration tapped newly appointed George Tidmarsh as acting Center for Biologics Evaluation ...
We recently published 10 Stocks That Jim Cramer Talked About. Novo Nordisk A/S (NYSE:NVO) is one of the stocks Jim Cramer ...
Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results